GCM
AGN

Grisanti Capital Management’s Allergan plc AGN Stock Holding History

Grisanti Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-31,755
Closed -$6.51M – 82
2017
Q3 		$6.51M Buy
31,755
+1,502
+5% +$349K 2.67% 18
2017
Q2 		$7.35M Sell
30,253
-564
-2% -$133K 3.17% 16
2017
Q1 		$7.36M Buy
30,817
+460
+2% +$107K 3.09% 14
2016
Q4 		$6.38M Sell
30,357
-21,845
-42% -$4.53M 2.87% 18
2016
Q3 		$12M Buy
52,202
+9,940
+24% +$2.43M 5.81% 6
2016
Q2 		$9.77M Buy
+42,262
New +$9.74M 5.39% 9

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Grisanti Capital Management's AGN Position: Q4 2017 in Review

Grisanti Capital Management sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 31,755 shares — an estimated $6.51M sold.

Grisanti Capital Management first reported a position in AGN in Q2 2016 and held it in 6 quarters. The position peaked at $12M in Q3 2016. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Grisanti Capital Management reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Grisanti Capital Management sold 31,755 Allergan plc shares in Q4 2017, an estimated $6.51M.
  • Grisanti Capital Management first reported a position in Allergan plc in Q2 2016 and held it in 6 quarters.
  • Grisanti Capital Management's Allergan plc position peaked at $12M in Q3 2016.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Grisanti Capital Management's 13F filing for Q4 2017, filed 7 Feb 2018.